2025-05-28T13:59:34-05:00 2024-12-31 481142819 BRIDGEBUILDER TAX AND LEGAL SERVICES PA 9325 PFLUMM RD LENEXA KS 66215 990 2024-01-01 042720360 ACCP FOUNDATION LTD PHAR 9134923311 13000 WEST 87TH STREET PARKWAY LENEXA KS 66215 MICHAEL S MADDUX PHARM D FCCP TRUSTEE 9134923311 2025-05-28 1 1 BRIAN G SCOTT P01605333 9134926008 2024 2025-03-06 01:10:19Z X MICHAEL S MADDUX PHARM 13000 WEST 87TH STREET PARKWAY LENEXA KS 66215 648923 0 X WWW.ACCPFOUNDATION.ORG X 1981 MA ADVANCE HUMAN HEALTH BY SUPPORTING AND DISSEMINATING PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION. 14 13 0 596 0 0 0 127510 376137 391849 30847 129195 0 0 406984 648554 0 94047 0 0 0 13513 0 0 4054 475737 473703 475737 581263 -68753 67291 1560881 5236664 65744 229370 1495137 5007294 X ADVANCE HUMAN HEALTH BY SUPPORTING AND DISSEMINATING PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION. 1 1 353605 391849 SUBSCRIPTION SUPPLEMENTS AND PUBLICATION SUBSCRIPTIONS - ORGANIZATION PUBLISHES TWO SCIENTIFIC JOURNALS THAT CONTAIN CLINICAL RESEARCH ARTICLES AND PROVIDE EVALUATION OF DRUGS AND DRUG TREATMENTS. 94047 94047 RESEARCH GRANTS - PROVIDE RESEARCH GRANTS AND AWARDS TO SUPPORT CLINICAL PHARMACY RESEARCH. 447652 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 20 0 1 0 0 0 0 0 0 0 0 0 0 0 X 14 13 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 MA X X ACCP FOUNDATION LTD 9134923311 13000 WEST 87TH STREET PARKWAY LENEXA KS 66215 JAMES E TISDALE PHARM D FCCP BCPS CHAIR 2.00 X X 0 0 0 MICHAEL S MADDUX PHARM D FCCP EX OFFICIO MEMBER 1.00 40.00 X 0 0 0 WILLIAM A MILLER PHARM D FCCP DIRECTOR 1.00 X 2500 0 0 C LINDSAY DEVANE PHARM D FCCP EX OFFICIO MEMBER 1.00 X 0 0 0 JERRY L BAUMAN PHARM D FCCP EX OFFICIO MEMBER 1.00 X 0 0 0 KERI A SIMS PHARM D BCPS SECRETARY 16.00 24.00 X X 69782 104673 11103 CYNTHIA JACKEVICIUS DIRECTOR 1.00 X 0 0 0 TITILOLA M AFOLABI PHARMD FCCP DIRECTOR 1.00 X 0 0 0 KELLY E CAUDLE PHARMD PHD FCC DIRECTOR 1.00 X 0 0 0 HENRY DUNNENBERGER IV PHARMD BCP DIRECTOR 1.00 X 0 0 0 CANDICE L GARWOOD PHARMD FCCP B EX OFFICIO DIRECTOR 1.00 X 0 0 0 MARY WL LEE PHARMD BCPS FCCP DIRECTOR 1.00 X 0 0 0 P DAVID ROGERS PHARMD PHD FCC DIRECTOR 1.00 X 0 0 0 MARC H SCHEETZ PHARMD FCCP TREASURER 1.00 X X 0 0 0 KATHLEEN STRINGER PHARMD FCCP DIRECTOR 1.00 X 0 0 0 KATIE J SUDA PHARMD FCCP DIRECTOR 1.00 X 0 0 0 EVA M VASQUEZ PHARMD FCCP BCPS DIRECTOR 1.00 X 0 0 0 72282 104673 11103 0 0 1 0 0 67148 60362 127510 SUBSCRIPTION CONTRACT 611430 301365 301365 WILEY AGREEMENT 513120 90484 90484 391849 59527 59527 70037 369 69668 69668 69668 0 67148 0 0 648554 461517 0 59527 X 94047 94047 11978 4792 3593 3593 1535 613 461 461 8546 8546 10000 10000 3772 3772 450340 348200 102140 1045 1045 581263 447652 129557 4054 18232 718763 14524 1542649 4503377 1560881 5236664 65744 229370 65744 229370 X 1495137 4983065 24229 1495137 5007294 1560881 5236664 X 67291 33314 3411552 X 1 X 0 1 0 X 127510 127510 338350 333814 390584 376137 391849 1830734 338350 333814 390584 376137 519359 1958244 102136 102136 0 102136 102136 1856108 31643 30786 35573 38190 59527 195719 31643 30786 35573 38190 59527 195719 369993 364600 426157 414327 578886 2153963 0.86170 0.90690 0.09090 0.09310 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS THEREFORE EXEMPT FROM FEDERAL INCOME TAXES. THE ORGANIZATION IS SUBJECT TO INCOME TAXES ON ALL UNRELATED BUSINESS INCOME. UNCERTAIN TAX PROVISIONS, IF ANY, ARE RECORDED IN ACCORDANCE WITH FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ACCOUNTING STANDARDS CODIFICATION (ASC) 740, INCOME TAXES, WHICH REQUIRE THE RECOGNITION OF A LIABILITY FOR TAX POSITIONS TAKEN THAT DO NOT MEET THE MORE-LIKELY-THAN-NOT STANDARD THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAXING AUTHORITIES. THERE IS NO LIABILITY FOR UNCERTAIN TAX POSITIONS RECORDED AT DECEMBER 31, 2024 AND 2023. THE ORGANIZATION'S INCOME TAX FILINGS ARE SUBJECT TO EXAMINATION BY VARIOUS TAXING AUTHORITIES. THE ORGANIZATION'S OPEN EXAMINATION PERIODS ARE 2021 AND FORWARD. FRONTIER FUND 67148 67148 67148 67148 1 MIDWESTERN UNIVERSITY 19555 NORTH 59TH AVENUE GLENDALE AZ 85308 363377698 28900 0 FMV GRANTS AND AWARDS UNIVERSITY OF NORTH CAROLINA 104 AIRPORT DRIVE SUITE 2200 CHAPEL HILL NC 27599 566001393 15147 0 FMV GRANTS AND AWARDS RUTGERS THE STATE UNIVERSITY 33 KNIGHTSBRIDGE ROAD C281 PISCATAWAY NJ 08854 226001086 5000 0 FMV GRANTS AND AWARDS UNIVERSITY OF HOUSTON SYSTEM TREASURERS OFFICE PO BOX 988 HOUSTON TX 77001 746001399 40000 0 FMV GRANTS AND AWARDS UNIVERSITY OF FLORIDA PO BOX 113201 SUITE 1250 EAST CAMPUS OFFICE BLDG GAINESVILLE FL 32611 596002052 5000 0 FMV GRANTS AND AWARDS 0 0 0 0 0 0 0 0 0 KERI A SIMS PHARM D BCPS SECRETARY 69782 104673 0 0 0 0 0 9420 0 1683 69782 115776 0 0 FORM 990, PART III, LINE 2 EFFECTIVE DECEMBER 1, 2024, UNDER AN AGREEMENT OF MERGER, PHARMACOTHERAPY PUBLICATIONS, INC. (EIN 04-2720360) MERGED WITH ACCP-FOUNDATION (EIN 43-1717075). THE MERGED ORGANIZATION NOW OPERATES UNDER THE NAME OF ACCP FOUNDATION, LTD. THE FOCUS OF ACCP FOUNDATION, LTD. WILL CONTINUE TO BE CONTAINED WITHIN THE DEFINING GOALS OF ACCP-F AND PPI: TO PUBLISH A SCIENTIFIC JOURNAL WITH THE EDUCATION, REVIEW, AND PUBLICATION OF RESEARCH AND STUDY RESULTS OF DRUGS AND THE INTERACTION OF PHARMACEUTICALS; AND SUPPORT AND DISSEMINATE PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION TO ADVANCE HUMAN HEALTH AND OTHER CHARITABLE, RESEARCH, AND SCIENTIFIC PURPOSES. FORM 990, PART III, LINE 3 EFFECTIVE DECEMBER 1, 2024, UNDER AN AGREEMENT OF MERGER, PHARMACOTHERAPY PUBLICATIONS, INC. (EIN 04-2720360) MERGED WITH ACCP-FOUNDATION (EIN 43-1717075). THE MERGED ORGANIZATION NOW OPERATES UNDER THE NAME OF ACCP FOUNDATION, LTD. THE FOCUS OF ACCP FOUNDATION, LTD. WILL CONTINUE TO BE CONTAINED WITHIN THE DEFINING GOALS OF ACCP-F AND PPI: TO PUBLISH A SCIENTIFIC JOURNAL WITH THE EDUCATION, REVIEW, AND PUBLICATION OF RESEARCH AND STUDY RESULTS OF DRUGS AND THE INTERACTION OF PHARMACEUTICALS; AND SUPPORT AND DISSEMINATE PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION TO ADVANCE HUMAN HEALTH AND OTHER CHARITABLE, RESEARCH, AND SCIENTIFIC PURPOSES. FORM 990, PART VI, SECTION A, LINE 4 THE ORGANIZATION AMENDED THEIR BY-LAWS AND ARTICLES OF INCORPORATION AND RESTATED THE NAME OF THE ORGANIZATION AS ACCP FOUNDATION, LTD. THE ORGANIZATION WAS FORMERLY KNOWN AS PHARMACOTHERAPY PUBLICATIONS, INC. SEE ATTACHED ARTICLES OF INCORPORATION AND ARTICLES OF MERGER. FORM 990, PART VI, SECTION B, LINE 11B ORGANIZATION'S PROCESS TO REVIEW FORM 990: THE RETURN WILL BE REVIEWED BY THE FULL BOARD OF DIRECTORS. A COPY OF THE RETURN WILL BE MAINTAINED FOR PUBLIC INSPECTION. FORM 990, PART VI, SECTION B, LINE 12C ANY POTENTIAL AUTHOR, EDITOR, EDITORIAL BOARD MEMBER, REVIEWER, OR CONTRIBUTOR TO AN ACCP FOUNDATION PUBLICATION OR PROGRAM WILL BE EVALUATED TO DETERMINE WHETHER THE POTENTIAL FOR EXCESSIVE REAL OR PERCEIVED CONFLICT OF INTEREST EXISTS. IF THIS EVALUATION DETERMINES THAT CONFLICT OF INTEREST DOES EXIST, THAT INDIVIDUAL WILL BE EXCUSED FROM DUTY OR PARTICIPATION IN THAT PROJECT. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS ARE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST AND POSTED ON THE SECRETARY OF STATE WEBSITE OF THE COMMONWEALTH OF MASSACHUSSETS. FORM 990, PART IX, LINE 11G CONTRACTED SERVICES: PROGRAM SERVICE EXPENSES 55,366. MANAGEMENT AND GENERAL EXPENSES 18,456. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 73,822. JACCP EDITORS: PROGRAM SERVICE EXPENSES 2,759. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,759. SCIENTIFIC EDITORS COMMITTEE: PROGRAM SERVICE EXPENSES 7,737. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 7,737. BOARD OF DIRECTORS: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 43,693. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 43,693. CONSULTING: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 2,000. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,000. DEVELOPMENT EDITORS: PROGRAM SERVICE EXPENSES 131,251. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 131,251. MANUSCRIPT SCIENTIFIC EDITING: PROGRAM SERVICE EXPENSES 151,087. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 151,087. OVERHEAD: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 36,333. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 36,333. BANK CHARGES/MISC EXP: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 141. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 141. ORG DUES RI DIRECTOR: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 767. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 767. LEGACY FUND DEVELOPMENT: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 750. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 750. FORM 990, PART XI, LINE 9: NET ASSETS FROM ACCP-FOUNDATION MERGER 3,411,552. AMERICAN COLLEGE OF CLINICAL PHARMACY 13000 W 87TH STREET PKWY LENEXA KS 66215 431183142 PROMOTE QUALITY CLINICAL PHARMACY PRACTICE MO 501(C)(6) N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 AMERICAN COLLEGE OF CLINICAL PHARMACY P 36333 FMV AMERICAN COLLEGE OF CLINICAL PHARMACY C 60362 CASH